|
Premier US and UK e-learning providers in the
Life Sciences offer multinational pharmaceutical companies a single end-to-end
solution for their enterprise knowledge needs.
San Francisco, CA, and London, England, May
9, 2005 — As major multinational pharmaceutical, biotechnology,
medical device, and agricultural companies grasp e-learning as the primary
method of increasing workforce productivity, GeneEd and Zenosis, the premier
providers of life science e-learning in the US and Europe respectively,
announced today that they have formed a strategic partnership that will
utilize their complementary platforms.
GeneEd, the leader in scientific and technical training, has teamed with
Zenosis, the leader in regulatory and compliance training, to offer life
science organizations a single, integrated system that combines the best
content from each organization. The new system will offer users the most
extensive learning and knowledge transfer service available. The range
of pharmaceutical e-learning includes discovery and development tools
(pharmacogenetics, proteomics, microarrays), regulatory and compliance
training (GxPs, eCTD, adverse events, pharmacovigilance), sales force
therapeutic area, disease-state training, manufacturing product scale-up
training, physician product education, and patient education and outreach.
The combination of Zenosis' 'nano-training' - the delivery of required
global regulatory and compliance directives and recommendations in a 'just-in-time'
format - and GeneEd's scalable "configured library"- based upon the reusable
learning object strategy developed in the software industry - stands in
contrast to other e-learning vendors custom "one-off" solutions that feature
little scalability or reuse, or companies that require pharmaceutical
clients to adapt proprietary solutions. The success of the two companies'
respective platforms is reflected in the adoption rates of both content
libraries and the viewing/repurposing tools world-wide.
"Major global customers such as Amgen, Genentech, Pfizer and AstraZeneca
can now benefit from a comprehensive library of e-learning" Sunil
Maulik, Ph.D., CEO of GeneEd. "With the formation of this strategic
partnership with Zenosis, we can help our clients with the development,
regulatory, and sales hurdles they face in providing cutting-edge cures
for human health." Simon Burgess, CEO of Zenosis, concurred, "With
this product and distribution integration partnership, we can provide
clients a balanced viewpoint of the regulatory and compliance issues they
face in the US, Europe, and Asia."
The companies anticipate the first products from the integration to be
available in the fourth quarter, with a comprehensive solution-set available
shortly thereafter.
About GeneEd
GeneEd, Inc. was founded in 1997 to provide life science and health care
e-learning solutions for the pharmaceutical, biotechnology, hospital/HMO,
and instrument and medical device industries. GeneEd's Life Science industry
customers include AstraZeneca, Pfizer, the ALZA division of Johnson &
Johnson, Celera, Bio-Rad, and IBM Life Sciences, among others (http://www.geneed.com/clients/index.html).
GeneEd utilizes the best life science content, combined with advanced
e-learning development technology, to rapidly create basic and advanced
curricula in the areas of genomics, therapeutic area training (for clinical
research, product development, and sales/marketing teams), computer assisted
drug design, drug discovery and development, pharmacogenomics and clinical
genomics, bioinformatics and microarray informatics, and therapeutic and
diagnostic products. GeneEd, Inc. is a privately held company headquartered
in San Francisco, California. Visit http://www.GeneEd.com
for additional information.
About Zenosis
Zenosis was established in 2002 to provide the global life science industry
with comprehensive regulatory e-learning and knowledge building system
that is always up-to-date and accessible. After extensive test marketing
with many of the global leaders in the pharmaceutical industry, Zenosis
formally launched its ‘web-based training’ in November 2004.
Zenosi has since received acclaim from many of the world's leading pharmaceutical
companies whom actively use the ‘Zenosis system’ in Europe,
USA, and South East Asia - AstraZeneca, Wyeth, Merck, Organon, Schering
and Nycomed to name but a few. Visit www.zenosis.com
for additional information.
|
